Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Omalizumab
(D05251)		[1] Omalizumab[1] Omalizumab (D05251) 💬[1] FCER1A 💬[4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[7] 46, 53, 65, 98, 162, 226, 299 💬
2Omalizumab (Xolair)
(D05251)		[1] Omalizumab[1] Omalizumab (D05251) 💬[1] FCER1A 💬[4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 65 💬
3Recombinant humanized monoclonal antibody omalizumab to IgE
(D05251)		[1] Omalizumab[1] Omalizumab (D05251) 💬[1] FCER1A 💬[4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 299 💬
4Rituximab combined with Omalizumab
(D05251)		[2] Omalizumab,
Rituximab		[2] Rituximab ,
Omalizumab (D05251) 💬		[2] FCER1A,
MS4A1 💬		[5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 162 💬